Aksakal, M. Et Al. 2017. Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes. ORTHOPADE , vol.46, no.2 , 179-185.

Aksakal, M., Ermutlu, C., Ozkaya, G., & Ozkan, Y., (2017). Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes. ORTHOPADE , vol.46, no.2, 179-185.

Aksakal, M. Et Al. "Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes," ORTHOPADE , vol.46, no.2, 179-185, 2017

Aksakal, M. Et Al. "Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes." ORTHOPADE , vol.46, no.2, pp.179-185, 2017

Aksakal, M. Et Al. (2017) . "Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes." ORTHOPADE , vol.46, no.2, pp.179-185.

@article{article, author={M. Aksakal Et Al. }, title={Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome A prospective randomized study of functional outcomes}, journal={ORTHOPADE}, year=2017, pages={179-185} }